Central Trust CO Supernus Pharmaceuticals, Inc. Transaction History

Central Trust CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Oct 04, 2018	SELL	$42.7 - $56.55 $9,735 - $12,893	-228 Closed	0 $0
Q2 2018 Jul 09, 2018	SELL	$44.1 - $59.85 $1,764 - $2,394	-40 Reduced 14.93%	228 $0
Q1 2018 Apr 04, 2018	SELL	$37.15 - $46.9 $18,575 - $23,450	-500 Reduced 65.1%	268 $0
Q3 2017 Oct 17, 2017	BUY	$36.75 - $49.65 $28,224 - $38,131	768	768 $0

283

60.6M

27.7K

11.3K

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.11B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.